XS® system - The latest PT/INR Monitoring solution from Roche
Roche Diagnostics, the pioneer in Coagulation Monitoring systems, was
introducing its latest generation of Coagulation Monitoring system in 2006,
the CoaguChek XS system, which is CE marked and FDA approved since February
The first model, the Roche CoaguChek system, has been FDA approved since
1993. Its successor, the CoaguChek S system was launched in 2000, which
is CE marked and FDA approved but not for Patient Self-Testing, and produces
results equal in accuracy to laboratory tests.
Through several innovative practical e.g. smaller size and weight, side
and top blood dosing options, etc. and safety features, the CoaguChek XS
system will help you to provide easier access to Coagulation Self-Testing.
This Roche CoaguChek system provides patients with more independence and
increases their quality of life. This is one of the reasons why the CoaguChek
systems are used by over 150,000 people in many countries. (2005)